Saffron extract 14 mg
Natural health product licensed in Canada
- Other names
- Affron
- Licence holder
- WN Pharmaceuticals Ltd
- NPN or DIN-HM
- 80105655
- Status
- Active licence
- Licence date
- 26 October 2020
- Revision date
- 21 February 2022
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Crocus sativus Source : Stigmates Potency : 3.48 % Crocin | Not specified | Not calculated |
| Crocus sativus Source : Stigmates Extract : Matériel brut sec Extraction ratio : 3:1 Dry plant equivalent : 42 mg Potency : 0.03 % 2,6,6-Trimethylcyclohexa-1,3-diene-1-carbaldehyde | 14 mg | Not calculated |
Non-medicinal ingredients
Acide stéarique, NA, Eau purifiée, Cellulose microcristalline, Silice, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 2 Tous les jours |
| Adolescents | minimum: 12 years | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Helps to support mood balance. Helps to support mood balance in adolescents and youths 12 years and over. Affron helps to relieve restlessness and/or nervousness (calmative). Supports positive effects on symptoms of perceived stress such as, fatigue, weariness, and irritability. Helps to reduce the symptoms of perceived stress, such as fatigue, weariness, and irritability.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If symptoms persist or worsen, consult a physician. If you suffer from any psychological disorder and/or condition such as frequent anxiety or depression, consult a physician prior to use. Consult a physician prior to use if you are taking antidepressants. Do not use if you are taking blood thinners/anticoagulants or have a bleeding disorder. Do not use if you are pregnant or breastfeeding. Some people may experience anxiety/nervousness, increased appetite, nausea and headache, in which case, discontinue use. Keep out of reach of children.
Source
Official Health Canada record, licence 80105655
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging